Light Mode
$0.3425 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.3425, $0.0085 below the day’s high of $0.3510
-0.82 (-70.47%) / 6M
Momentum, market sentiment, and recent alerts
TRAW reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -87.4%.
No alerts for TRAW in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Traws Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the identification and development of oncology therapeutics. It focuses on discovering and developing small molecule drug candidates to treat cancer. The company was founded by Ramesh Kumar and E. Premkumar Reddy on December 22, 1998 and is headquartered in Newtown, PA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.